117 related articles for article (PubMed ID: 15755000)
1. Epidemiological aspects of ovarian malignancies in North Sardinia in the period 1992-2001.
Cossu A; Budroni M; Capobianco G; Pirino D; Palmieri G; Dessole S; Tanda F; Cesaraccio R; Cherchi PL
Eur J Gynaecol Oncol; 2005; 26(1):47-50. PubMed ID: 15755000
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for different histological types of ovarian cancer.
Parazzini F; Chiaffarino F; Negri E; Surace M; Benzi G; Franceschi S; Fedele L; La Vecchia C
Int J Gynecol Cancer; 2004; 14(3):431-6. PubMed ID: 15228415
[TBL] [Abstract][Full Text] [Related]
3. Low-malignant potential epithelial tumors of the ovary: a clinicopathological study.
Hassan E; Koumantaki Y; Stefanaki K; Matalliotakis I; Koumantakis E
Eur J Gynaecol Oncol; 1998; 19(2):170-2. PubMed ID: 9611060
[TBL] [Abstract][Full Text] [Related]
4. Ovarian surface epithelial neoplasms in the pediatric population: incidence, histologic subtype, and natural history.
Hazard FK; Longacre TA
Am J Surg Pathol; 2013 Apr; 37(4):548-53. PubMed ID: 23388124
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR
J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer.
Nielsen JS; Jakobsen E; Hølund B; Bertelsen K; Jakobsen A
Int J Gynecol Cancer; 2004; 14(6):1086-96. PubMed ID: 15571614
[TBL] [Abstract][Full Text] [Related]
7. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of ovarian cancer in North Sardinia, Italy, during the period 1992-2010.
Tanda ET; Budroni M; Cesaraccio R; Palmieri G; Palomba G; Capobianco G; Dessole M; Dessole S; Cossu A
Eur J Gynaecol Oncol; 2015; 36(1):69-72. PubMed ID: 25872338
[TBL] [Abstract][Full Text] [Related]
9. [Endometriosis as a risk factor for ovarian cancer].
Vargas-Hernández VM
Cir Cir; 2013; 81(2):163-8. PubMed ID: 23522320
[TBL] [Abstract][Full Text] [Related]
10. [Serous and mucinous epithelial ovarian tumors--a clinicopathologic study of 116 cases].
Giurgea NL; Pitrop M; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):389-94. PubMed ID: 23077925
[TBL] [Abstract][Full Text] [Related]
11. Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.
Simons M; Ezendam N; Bulten J; Nagtegaal I; Massuger L
Int J Gynecol Cancer; 2015 Sep; 25(7):1208-15. PubMed ID: 25978291
[TBL] [Abstract][Full Text] [Related]
12. Alcohol consumption and ovarian cancer risk in a population-based case-control study.
Peterson NB; Trentham-Dietz A; Newcomb PA; Chen Z; Hampton JM; Willett WC; Egan KM
Int J Cancer; 2006 Nov; 119(10):2423-7. PubMed ID: 16921486
[TBL] [Abstract][Full Text] [Related]
13. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
14. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade.
Oberaigner W; Minicozzi P; Bielska-Lasota M; Allemani C; de Angelis R; Mangone L; Sant M;
Acta Oncol; 2012 Apr; 51(4):441-53. PubMed ID: 22313338
[TBL] [Abstract][Full Text] [Related]
15. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
[TBL] [Abstract][Full Text] [Related]
16. Borderline ovarian tumours: retrospective analysis of twenty-one cases.
Saygili U; Uslu T; Erten O; Doğan E
Eur J Gynaecol Oncol; 1998; 19(2):182-5. PubMed ID: 9611063
[TBL] [Abstract][Full Text] [Related]
17. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining.
Kritpracha K; Hanprasertpong J; Chandeying V; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2005 Jun; 31(3):268-76. PubMed ID: 15916666
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of borderline ovarian tumors.
Harlow BL; Weiss NS; Lofton S
J Natl Cancer Inst; 1987 Jan; 78(1):71-4. PubMed ID: 3025504
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of ovarian endometriosis in epithelial ovarian cancer.
Jimbo H; Yoshikawa H; Onda T; Yasugi T; Sakamoto A; Taketani Y
Int J Gynaecol Obstet; 1997 Dec; 59(3):245-50. PubMed ID: 9486515
[TBL] [Abstract][Full Text] [Related]
20. GATA6: a new predictor for prognosis in ovarian cancer.
Shen W; Niu N; Lawson B; Qi L; Zhang J; Li T; Zhang H; Liu J
Hum Pathol; 2019 Apr; 86():163-169. PubMed ID: 30633927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
